new indications for glp 1 drugs Long-term Success of GLP-1s Hinges on More Than Just a Prescription GLP-1 Drug Overdose

February 3, 2026: Man Sues Ozempic, Claims the Injectable Semaglutide Caused Him to Lose Sight A man from Ohio has filed a legal claim against Ozempics manufacturer, Novo Nordisk, alleging that he developed NAION after taking Ozempic as prescribed

If GLP-1 medications have become too expensive, too frustrating, or simply not effective enough, it may be time to compare your surgical options

9.2 Criteria suggesting true biological failure Conversely, certain characteristics indicate that abandonment of a peptide system is likely justified on biological grounds

2 In a press release, John F

Christian Wber: has received honoraria consultancy/speaking from Apomedica, Curelator, Eli Lilly, Grnenthal, Hermes, Lundbeck, Novartis, Pfizer, Ratiopharm/Teva, and Stada

GLP-1 medications are known as subcutaneous injections, which means they must be injected under the skin and into the fatty layer just below the surface